Unlocking
the future
of medicine

About us

Offering an unrivalled modular platform and tailored hyper-targeting is how we stand apart

Pipeline

Reducing the impact of cancer and infectious diseases on people’s lives is why we’re here

Innovation and research

Pushing the boundaries of human advancement in medicine is what drives us every day

Investors
 
 
 

A vaccine platform that unlocks unlimited possibilities for the future of medicine

The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.

Highlights

Nykode Therapeutics Announces Expansion of Clinical Collaboration with Roche ...

Read More
01 June 2023

Nykode Therapeutics to Present at Jefferies Healthcare Conference

Read More
30 May 2023

Nykode Therapeutics – 1Q 2023 Financial Results – presentation

Read More
12 May 2023

Nykode Therapeutics – Final Results from the Phase 2 ...

Read More
19 April 2023

Nykode Therapeutics announces positive final results from its Phase ...

Read More
18 April 2023

Nykode Therapeutics announces positive final results from its Phase ...

Read More
18 April 2023

Nykode Therapeutics – 4Q 2022 Financial Results – presentation

Read More
28 February 2023

Nykode Therapeutics to announce financial results for the fourth ...

Read More
22 February 2023

Nykode Therapeutics Announces Collaboration with The GOG Foundation, Inc. ...

Read More
10 February 2023